NIV vs NHF for hypercapnic respiratory failure in COPD

Medical Illustration by Dr Ciléin Kearns

Our latest study compared the current “Gold Standard” treatment in COPD: Non-Invasive Ventilation (NIV, which can be poorly tolerated in up to 20% of patients) against a possible future alternative strategy of Nasal High-Flow Oxygen (NHF).

Check out Dr Steven McKinstry presenting a short video summary of this publication in Respirology. The bottom line, according to co-author Dr James Fingleton, was that “NHF is a potential new treatment option for people with COPD and hypercapnic respiratory failure which may be better tolerated than the current gold-standard treatment, but we need trials comparing the two treatments over longer periods of time in people’s own homes to be sure.”